These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 20416090)
21. The immunologically distinct O antigens from Francisella tularensis subspecies tularensis and Francisella novicida are both virulence determinants and protective antigens. Thomas RM; Titball RW; Oyston PC; Griffin K; Waters E; Hitchen PG; Michell SL; Grice ID; Wilson JC; Prior JL Infect Immun; 2007 Jan; 75(1):371-8. PubMed ID: 17074846 [TBL] [Abstract][Full Text] [Related]
22. Characterization of Schu S4 Cunningham AL; Mann BJ; Qin A; Santiago AE; Grassel C; Lipsky M; Vogel SN; Barry EM Virulence; 2020 Dec; 11(1):283-294. PubMed ID: 32241221 [TBL] [Abstract][Full Text] [Related]
23. ClpB mutants of Francisella tularensis subspecies holarctica and tularensis are defective for type VI secretion and intracellular replication. Alam A; Golovliov I; Javed E; Sjöstedt A Sci Rep; 2018 Jul; 8(1):11324. PubMed ID: 30054549 [TBL] [Abstract][Full Text] [Related]
24. Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species. Moreau GB; Qin A; Mann BJ J Bacteriol; 2018 Feb; 200(4):. PubMed ID: 29109188 [TBL] [Abstract][Full Text] [Related]
25. Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain. Sutera V; Hennebique A; Lopez F; Fernandez N; Schneider D; Maurin M Int J Antimicrob Agents; 2020 Dec; 56(6):106153. PubMed ID: 32911069 [TBL] [Abstract][Full Text] [Related]
26. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity. Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440 [No Abstract] [Full Text] [Related]
27. Lipophilic prodrugs of FR900098 are antimicrobial against Francisella novicida in vivo and in vitro and show GlpT independent efficacy. McKenney ES; Sargent M; Khan H; Uh E; Jackson ER; San Jose G; Couch RD; Dowd CS; van Hoek ML PLoS One; 2012; 7(10):e38167. PubMed ID: 23077474 [TBL] [Abstract][Full Text] [Related]
28. Characterization of Francisella tularensis Schu S4 mutants identified from a transposon library screened for O-antigen and capsule deficiencies. Rasmussen JA; Fletcher JR; Long ME; Allen LA; Jones BD Front Microbiol; 2015; 6():338. PubMed ID: 25999917 [TBL] [Abstract][Full Text] [Related]
29. Characterization of stable, constitutively expressed, chromosomal green and red fluorescent transcriptional fusions in the select agent bacterium, Francisella tularensis Schu S4 and the surrogate type B live vaccine strain (LVS). Su S; Saldanha R; Pemberton A; Bangar H; Kawamoto SA; Aronow B; Hassett DJ; Lamkin TJ Appl Microbiol Biotechnol; 2013 Oct; 97(20):9029-41. PubMed ID: 23852642 [TBL] [Abstract][Full Text] [Related]
30. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in Cantlay S; Haggerty K; Horzempa J J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588 [No Abstract] [Full Text] [Related]
31. Guanylate-Binding Proteins Are Critical for Effective Control of Mohammadi N; Lindgren H; Golovliov I; Eneslätt K; Yamamoto M; Martin A; Henry T; Sjöstedt A Front Cell Infect Microbiol; 2020; 10():594063. PubMed ID: 33363054 [No Abstract] [Full Text] [Related]
32. Evasion of IFN-γ signaling by Francisella novicida is dependent upon Francisella outer membrane protein C. Nallaparaju KC; Yu JJ; Rodriguez SA; Zogaj X; Manam S; Guentzel MN; Seshu J; Murthy AK; Chambers JP; Klose KE; Arulanandam BP PLoS One; 2011 Mar; 6(3):e18201. PubMed ID: 21483828 [TBL] [Abstract][Full Text] [Related]
33. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization. Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266 [TBL] [Abstract][Full Text] [Related]
34. Description of Francisella hispaniensis sp. nov., isolated from human blood, reclassification of Francisella novicida (Larson et al. 1955) Olsufiev et al. 1959 as Francisella tularensis subsp. novicida comb. nov. and emended description of the genus Francisella. Huber B; Escudero R; Busse HJ; Seibold E; Scholz HC; Anda P; Kämpfer P; Splettstoesser WD Int J Syst Evol Microbiol; 2010 Aug; 60(Pt 8):1887-1896. PubMed ID: 19783615 [TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of absent in melanoma 2-inflammasome activation in Alqahtani M; Ma Z; Miller J; Yu J; Malik M; Bakshi CS Front Microbiol; 2023; 14():1188112. PubMed ID: 37266012 [No Abstract] [Full Text] [Related]
36. The use of resazurin as a novel antimicrobial agent against Francisella tularensis. Schmitt DM; O'Dee DM; Cowan BN; Birch JW; Mazzella LK; Nau GJ; Horzempa J Front Cell Infect Microbiol; 2013; 3():93. PubMed ID: 24367766 [TBL] [Abstract][Full Text] [Related]
37. Complement C3 as a Prompt for Human Macrophage Death during Infection with Francisella tularensis Strain SCHU S4. Brock SR; Parmely MJ Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28739830 [TBL] [Abstract][Full Text] [Related]
38. Characterization of a Unique Outer Membrane Protein Required for Oxidative Stress Resistance and Virulence of Francisella tularensis. Alqahtani M; Ma Z; Ketkar H; Suresh RV; Malik M; Bakshi CS J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378894 [No Abstract] [Full Text] [Related]
39. Francisella tularensis DeltapyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Horzempa J; O'Dee DM; Shanks RM; Nau GJ Infect Immun; 2010 Jun; 78(6):2607-19. PubMed ID: 20385757 [TBL] [Abstract][Full Text] [Related]
40. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Aperis G; Fuchs BB; Anderson CA; Warner JE; Calderwood SB; Mylonakis E Microbes Infect; 2007 May; 9(6):729-34. PubMed ID: 17400503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]